4.7 Article

Aerosol, chemical and physical properties of dry powder synthetic lung surfactant for noninvasive treatment of neonatal respiratory distress syndrome

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome

Susan Boc et al.

Summary: This study developed and characterized a spray-dried powder aerosol formulation of a commercially available surfactant formulation, Survanta (R) intratracheal suspension, using the excipient enhanced growth (EEG) approach. The inclusion of l-leucine in the formulation significantly reduced primary particle size and increased the fraction of submicrometer particles, resulting in good aerosolization performance with low moisture content.

AAPS PHARMSCITECH (2021)

Editorial Material Respiratory System

Advances in synthetic lung surfactant protein technology

Frans J. Walther et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2019)

Article Biochemistry & Molecular Biology

Stability of an amphipathic helix-hairpin surfactant peptide in liposomes

Alan J. Waring et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)

Article Multidisciplinary Sciences

Aerosol delivery of synthetic lung surfactant

Frans J. Walther et al.

PEERJ (2014)

Article Biochemistry & Molecular Biology

Structure of mini-B, a functional fragment of surfactant protein B, in detergent micelles

Muzaddid Sarker et al.

BIOCHEMISTRY (2007)

Article Biochemical Research Methods

Trehalose-protected lipid membranes for determining membrane protein structure and insertion

Ming Tang et al.

JOURNAL OF MAGNETIC RESONANCE (2007)

Article Biochemistry & Molecular Biology

Surface activity in situ, in vivo, and in the captive bubble surfactometer

S Schurch et al.

COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY (2001)